ATE174589T1 - Verfahren zur herstellung von piperidinderivaten - Google Patents

Verfahren zur herstellung von piperidinderivaten

Info

Publication number
ATE174589T1
ATE174589T1 AT94920762T AT94920762T ATE174589T1 AT E174589 T1 ATE174589 T1 AT E174589T1 AT 94920762 T AT94920762 T AT 94920762T AT 94920762 T AT94920762 T AT 94920762T AT E174589 T1 ATE174589 T1 AT E174589T1
Authority
AT
Austria
Prior art keywords
piperidine derivatives
alkyl
compounds
producing piperidine
producing
Prior art date
Application number
AT94920762T
Other languages
English (en)
Inventor
Ambra Thomas E D
Original Assignee
Albany Molecular Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22176189&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE174589(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Albany Molecular Res Inc filed Critical Albany Molecular Res Inc
Application granted granted Critical
Publication of ATE174589T1 publication Critical patent/ATE174589T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/86Unsaturated compounds containing keto groups containing six-membered aromatic rings and other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT94920762T 1993-06-24 1994-06-21 Verfahren zur herstellung von piperidinderivaten ATE174589T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8310293A 1993-06-24 1993-06-24

Publications (1)

Publication Number Publication Date
ATE174589T1 true ATE174589T1 (de) 1999-01-15

Family

ID=22176189

Family Applications (3)

Application Number Title Priority Date Filing Date
AT94920762T ATE174589T1 (de) 1993-06-24 1994-06-21 Verfahren zur herstellung von piperidinderivaten
AT00200419T ATE254594T1 (de) 1993-06-24 1994-06-21 Verbindungen verwendbar als zwischenprodukte zur herstellung von piperidinderivate
AT03077245T ATE322473T1 (de) 1993-06-24 1994-06-21 Verfahren zur herstellung von verbindungen geeignet als zwischenprodukte

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT00200419T ATE254594T1 (de) 1993-06-24 1994-06-21 Verbindungen verwendbar als zwischenprodukte zur herstellung von piperidinderivate
AT03077245T ATE322473T1 (de) 1993-06-24 1994-06-21 Verfahren zur herstellung von verbindungen geeignet als zwischenprodukte

Country Status (16)

Country Link
US (9) US5589487A (de)
EP (4) EP0703902B1 (de)
JP (4) JP3034047B2 (de)
KR (2) KR100387347B1 (de)
AT (3) ATE174589T1 (de)
AU (1) AU670004B2 (de)
CA (1) CA2147126C (de)
DE (3) DE69434696T2 (de)
DK (3) DK0703902T3 (de)
ES (3) ES2261871T3 (de)
FI (1) FI109691B (de)
HU (1) HU226559B1 (de)
NO (2) NO308599B1 (de)
NZ (1) NZ268513A (de)
PT (2) PT1026147E (de)
WO (1) WO1995000482A1 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL174373B1 (pl) * 1992-08-03 1998-07-31 Sepracor Inc Środek farmaceutyczny zawierający metabolit terfenadyny
AU670004B2 (en) * 1993-06-24 1996-06-27 Albany Molecular Research, Inc. Piperidine derivatives and process for their production
US20020007068A1 (en) 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
EP2261208A1 (de) 1993-06-25 2010-12-15 Aventisub II Inc. Zwischenprodukte zur Herstellung antihistaminischer 4-Diphenylmethyl-/Diphenylmethoxy- Piperidinderivate
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
FI964565A7 (fi) * 1994-05-18 1996-11-14 Aventis Pharma Inc Menetelmiä antihistamiinisten piperidiinijohdosten vedettömien ja hydr atoituneiden muotojen, niiden polymorfien ja pseudomorfien, valmistami seksi
DE69624559T2 (de) * 1995-02-28 2003-07-10 Aventis Pharmaceuticals Inc., Bridgewater Arzneizubereitungen für piperidinalkanolderivate
US6201124B1 (en) * 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6153754A (en) * 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US5925761A (en) * 1997-02-04 1999-07-20 Sepracor Inc. Synthesis of terfenadine and derivatives
ZA985939B (en) * 1997-07-08 2000-01-10 Aristocrat Leisure Ind Pty Ltd Slot machine game and system with improved jackpot feature.
DK0998272T3 (da) * 1997-08-26 2003-08-25 Aventis Pharma Inc Farmaceutisk præparat til kombinationen piperidinoalkanoldekongestivum
US6194431B1 (en) * 1998-04-14 2001-02-27 Paul D. Rubin Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
AU2007200674C1 (en) * 1998-07-02 2011-02-24 Aventisub Llc Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
US6683094B2 (en) 1998-07-02 2004-01-27 Aventis Pharmaceuticals Inc. Antihistaminic piperidine derivatives and intermediates for the preparation thereof
US6700012B2 (en) 1998-07-02 2004-03-02 Aventis Pharmaceuticals Inc. Antihistaminic piperidine derivatives and intermediates for the preparation thereof
ATE485271T1 (de) * 1998-07-02 2010-11-15 Aventisub Ii Inc Antihistaminische piperidinderivate und zwischenprodukte zu ihrer herstellung
US6362375B1 (en) 1999-12-03 2002-03-26 College Of The Holy Cross Process for the preparation of aryl ketones generating reduced amounts of toxic byproducts
US6613906B1 (en) 2000-06-06 2003-09-02 Geneva Pharmaceuticals, Inc. Crystal modification
GB0018691D0 (en) * 2000-07-28 2000-09-20 Rolabo Sl Process
US6613907B2 (en) 2000-11-08 2003-09-02 Amr Technology, Inc. Process for the production of piperidine derivatives with microorganisms
US20030021849A1 (en) * 2001-04-09 2003-01-30 Ben-Zion Dolitzky Polymorphs of fexofenadine hydrochloride
PL366576A1 (en) * 2001-04-09 2005-02-07 Teva Pharmaceutical Industries Ltd. Polymorphs of fexofenadine hydrochloride
US6743941B2 (en) * 2001-06-15 2004-06-01 Aventis Pharma Deutschland Gmbh Process for the production of piperidine derivatives
SK712003A3 (en) * 2001-06-25 2003-12-02 Aurobindo Pharma Ltd Process for the preparation of 4-(cyclopropylcarbonyl)-alpha, alpha-dimethylphenylacetic acid
US6593499B2 (en) * 2001-08-29 2003-07-15 Council Of Scientific & Industrial Research Process for the preparation of phenyl ketones
EP1453509A2 (de) * 2001-11-08 2004-09-08 Teva Pharmaceutical Industries Ltd. Polymorphen einer fexofenadin-basis
CA2477088A1 (en) 2002-02-22 2003-10-02 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
JP2005532356A (ja) * 2002-06-10 2005-10-27 テバ ファーマシューティカル インダストリーズ リミティド 塩酸フェキソフェナジンの多型体xvi
US20050026890A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
US20050065183A1 (en) * 2003-07-31 2005-03-24 Indranil Nandi Fexofenadine composition and process for preparing
GB0319935D0 (en) 2003-08-26 2003-09-24 Cipla Ltd Polymorphs
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
EP1628959A2 (de) * 2004-04-26 2006-03-01 Teva Pharmaceutical Industries Ltd Polymorphe form xvi von fexofenadine-hydrochlorid
ITMI20041568A1 (it) * 2004-07-30 2004-10-30 Dipharma Spa "polimorfi di fexofenadina base"
US7498443B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of carebastine
US7498345B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of piperidine derivatives
WO2006037042A1 (en) * 2004-09-28 2006-04-06 Teva Pharmaceutical Industries Ltd. Fexofenadine crystal form and processes for its preparation thereof
US7841939B2 (en) 2005-09-09 2010-11-30 Igt Server based gaming system having multiple progressive awards
US7568973B2 (en) 2005-09-09 2009-08-04 Igt Server based gaming system having multiple progressive awards
US20070225217A1 (en) 2005-11-09 2007-09-27 Combinatorx, Incorporated Methods, compositions, and kits for the treatment of medical conditions
US7780520B2 (en) 2006-03-15 2010-08-24 Igt Gaming device having multiple different types of progressive awards
WO2007135693A2 (en) * 2006-05-18 2007-11-29 Ind-Swift Laboratories Limited Intermediates useful for the preparation of antihistaminic piperidine derivative
ITMI20061492A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
US8070597B2 (en) 2006-08-03 2011-12-06 Igt Gaming device and method having multiple progressive award levels and a secondary game for advancing through the progressive award levels
US9047733B2 (en) 2006-11-08 2015-06-02 Igt Gaming system and method for providing multiple level progressive awards with increased odds of winning higher level progressive awards
US20090306135A1 (en) 2008-03-24 2009-12-10 Mukesh Kumar Sharma Stable amorphous fexofenadine hydrochloride
WO2009136412A2 (en) * 2008-04-25 2009-11-12 Matrix Laboratories Limited PROCESS FOR PREPARATION OF 4-[4-(4-(HYDROXYDIPHENYLMETHYL)- 1-PIPERIDINYL]-1-OXOBUTYL]-α,α-DIMETHYLBENZENE ACETIC ACID METHYL ESTER AND USE THEREOF
WO2009137717A1 (en) 2008-05-07 2009-11-12 Cardioxyl Pharmaceuticals Inc. Novel nitroso compounds as nitroxyl donors and methods of use thereof
KR20110017365A (ko) * 2008-05-30 2011-02-21 페어필드 클리니컬 트라이얼즈 엘엘씨 피부 염증 및 변색을 위한 방법 및 조성물
US20100092479A1 (en) * 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
EP2289867A3 (de) 2009-08-19 2012-04-25 Jubilant Organosys Limited Verfahren zur Herstellung von 4-(4-Halogen-1-oxybutyl)-alpha,alpha-dimethylbenzolessigsäure oder Alkylestern davon
US20110130711A1 (en) * 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment
CN102070512B (zh) * 2009-11-21 2014-11-19 浙江华海药业股份有限公司 一种高纯度非索非那定及其中间体的合成路线与制备方法
US20110160200A1 (en) * 2009-11-23 2011-06-30 Cardioxyl Pharmaceuticals, Inc. Nitroxyl Progenitors for the Treatment of Pulmonary Hypertension
CN102962288A (zh) * 2012-11-21 2013-03-13 苏州江南航天机电工业有限公司 圆弧状大板与直板拼接工艺
ITMI20131652A1 (it) * 2013-10-07 2015-04-08 Dipharma Francis Srl Procedimento per la purificazione di derivati dell'acido 2-fenil-2-metil-propanoico
HUE047669T2 (hu) * 2015-10-22 2020-05-28 Sanofi Aventis Deutschland Eljárás fexofenadin és az eljárásban használt köztitermékek elõállítására
CN116178222B (zh) * 2021-11-29 2025-04-25 上海晓明检测技术服务有限公司 环磺酮代谢物m9的制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4028404A (en) * 1967-07-31 1977-06-07 Allen & Hanburys Limited Acetic acid derivatives
GB1242169A (en) * 1969-04-09 1971-08-11 Ucb Sa Piperidine derivatives
US3839431A (en) * 1970-07-13 1974-10-01 Squibb & Sons Inc Cyclopropylmethylphenylacetic acids and derivatives
US3898271A (en) * 1971-06-08 1975-08-05 Squibb & Sons Inc Cyclopropylmethylphenylacetic acids and derivatives
US3806526A (en) * 1972-01-28 1974-04-23 Richardson Merrell Inc 1-aroylalkyl-4-diphenylmethyl piperidines
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
BE794598A (fr) * 1972-01-28 1973-05-16 Richardson Merrell Inc Nouveaux derives olefiniques de piperidines substituees en 4 et leur procede de preparation
US3965257A (en) * 1972-01-28 1976-06-22 Richardson-Merrell Inc. Compositions and methods for the treatment of the symptoms of histamine induced allergic reactions
BE794596A (fr) * 1972-01-28 1973-05-16 Richardson Merrell Inc Piperidinoalcanone-oximes substituees et leur procede de preparation
US3931197A (en) * 1974-02-08 1976-01-06 Richardson-Merrell Inc. Substituted piperidine derivatives
US3941795A (en) * 1974-02-08 1976-03-02 Richardson-Merrell Inc. α-ARYL-4-SUBSTITUTED PIPERIDINOALKANOL DERIVATIVES
US3946022A (en) * 1974-03-04 1976-03-23 Richardson-Merrell Inc. Piperidine derivatives
US3956296A (en) * 1974-12-11 1976-05-11 A. H. Robins Company, Incorporated 1-Substituted-4-benzylpiperidines
US3922276A (en) * 1974-12-11 1975-11-25 Robins Co Inc A H 1-Substituted-4-benzylidenepiperidines
DD141422A5 (de) * 1978-01-27 1980-04-30 Schering Ag Verfahren zur herstellung von phenylessigsaeure-derivaten
US4285958A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkylene ketones, pharmaceutical compositions thereof and method of use thereof
US4254130A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4285957A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
GB8321157D0 (en) * 1983-08-05 1983-09-07 Fordonal Sa Piperidine derivatives
IT1200123B (it) 1985-09-27 1989-01-05 Ind Chimica Srl Procedimento per la preparazione di alfa-(p-terbutilfenil)-4-(idrossidifenilmetil)-1-piperidinobutanolo
US4742175A (en) * 1986-05-07 1988-05-03 Merrell Dow Pharmaceuticals Inc. Preparation of polymorphically pure terfenadine
HU226561B1 (en) * 1992-04-10 2009-04-28 Merrell Dow Pharma Process for preparation 4-diphenylmethyl piperidine derivatives and the novel intermediates thereof
PL174373B1 (pl) * 1992-08-03 1998-07-31 Sepracor Inc Środek farmaceutyczny zawierający metabolit terfenadyny
AU670004B2 (en) 1993-06-24 1996-06-27 Albany Molecular Research, Inc. Piperidine derivatives and process for their production
US20020007068A1 (en) * 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
EP2261208A1 (de) * 1993-06-25 2010-12-15 Aventisub II Inc. Zwischenprodukte zur Herstellung antihistaminischer 4-Diphenylmethyl-/Diphenylmethoxy- Piperidinderivate
US6147216A (en) 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
AU2001296994A1 (en) * 2000-10-06 2002-04-15 Regents Of The University Of California Nmda receptor channel blocker with neuroprotective activity

Also Published As

Publication number Publication date
US5663412A (en) 1997-09-02
NO955023D0 (no) 1995-12-12
NO994582D0 (no) 1999-09-21
JPH08511806A (ja) 1996-12-10
EP1026147A1 (de) 2000-08-09
PT1026147E (pt) 2004-04-30
DE69433346D1 (de) 2003-12-24
DE69415319D1 (de) 1999-01-28
JP3195297B2 (ja) 2001-08-06
CA2147126A1 (en) 1995-01-05
KR100387347B1 (ko) 2003-11-28
US7390906B2 (en) 2008-06-24
NO955023L (no) 1995-12-12
EP0703902A1 (de) 1996-04-03
HUT73235A (en) 1996-07-29
US5589487A (en) 1996-12-31
ATE322473T1 (de) 2006-04-15
KR960703398A (ko) 1996-08-17
EP1369409B1 (de) 2006-04-05
NO308599B1 (no) 2000-10-02
FI956270L (fi) 1995-12-27
HU226559B1 (en) 2009-03-30
US5581011A (en) 1996-12-03
ATE254594T1 (de) 2003-12-15
DE69434696D1 (de) 2006-05-18
DK1369409T3 (da) 2006-08-14
AU7174894A (en) 1995-01-17
EP1369409A1 (de) 2003-12-10
US20080227983A1 (en) 2008-09-18
US20060241303A1 (en) 2006-10-26
DE69415319T2 (de) 1999-06-10
AU670004B2 (en) 1996-06-27
EP0703902A4 (de) 1996-04-10
JP3658291B2 (ja) 2005-06-08
US5994549A (en) 1999-11-30
PT1369409E (pt) 2006-08-31
KR100387348B1 (ko) 2003-06-12
CA2147126C (en) 1999-08-24
EP0723958A1 (de) 1996-07-31
ES2211444T3 (es) 2004-07-16
US7238834B2 (en) 2007-07-03
DE69433346T2 (de) 2004-09-09
US5750703A (en) 1998-05-12
JP2001031650A (ja) 2001-02-06
NZ268513A (en) 1996-09-25
EP0703902B1 (de) 1998-12-16
EP1026147B1 (de) 2003-11-19
NO994582L (no) 1995-12-12
JP2002212166A (ja) 2002-07-31
JP3034047B2 (ja) 2000-04-17
ES2129130T3 (es) 1999-06-01
FI956270A0 (fi) 1995-12-27
FI109691B (fi) 2002-09-30
US20060052610A1 (en) 2006-03-09
US5578610A (en) 1996-11-26
DK1026147T3 (da) 2004-03-22
JP4124998B2 (ja) 2008-07-23
DE69434696T2 (de) 2006-11-16
DK0703902T3 (da) 1999-08-23
WO1995000482A1 (en) 1995-01-05
HU9503719D0 (en) 1996-02-28
ES2261871T3 (es) 2006-11-16
JPH11236373A (ja) 1999-08-31

Similar Documents

Publication Publication Date Title
ATE174589T1 (de) Verfahren zur herstellung von piperidinderivaten
ATE335726T1 (de) Verfahren zur herstellung von piperidinderivaten
ATE158568T1 (de) Verfahren zur herstellung von quaternären diestern
EP0937726A4 (de) Zwischenprodukte zur herstellung von duocarmycin-sa und derivaten davon, sowie ein verfahren zur herstellung der zwischenprodukte
DE69231874D1 (de) Verfahren zur herstellung von 4-substituierten azetidinon-derivaten
ATE207055T1 (de) Verfahren zur herstellung von 4-aryl-3- hydroxymethyl-piperidinen
DE69106003D1 (de) Verfahren und zwischenprodukte zur herstellung von azabicyclo[2.2.2]octan-3-iminen.
ATE383353T1 (de) Verfahren zur herstellung von 2-alkyl-3- aminothiophen derivate und 3-aminothiophen derivate
DE69311500D1 (de) 2,3-Diphenyl-5-pyrrolyl-furan Derivate, Verfahren und Zwischenprodukte für ihre Herstellung und ihre Verwendung als entzündungshemmende, antiallergische und blutplättchenaggregationshemmende Mittel
ATE278694T1 (de) Verfahren zur herstellung von substituierte piperidinepoxiden
ATE157971T1 (de) Verfahren zur herstellung von aminotriazin- derivaten
ATE311382T1 (de) Verfahren zur herstellung von 2-carbamoyl- pyridinen
ATE189453T1 (de) Verfahren zur herstellung von 2-cyanobiphenyl- verbindungen
DE3777464D1 (de) Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung.
ATE299498T1 (de) Verfahren zur herstellung von imidazolderivaten
DE69706504D1 (de) Verfahren zur herstellung von 3,4-dihydroxy-3-cyclobuten-1,2-dion
DE3772703D1 (de) Verfahren zur herstellung von penemen.
ATE329917T1 (de) 1h-pyrrolo 1,2-bö 1,2,4ötriazolederivate, zwischenprodukte und verfahren zur herstellung von 1h-1,2,4,-triazol-5-yl essigsäureesterderivate
DE3675249D1 (de) Verfahren zur herstellung von griseolinsaeurederivaten.
ATE115112T1 (de) Verfahren zur herstellung von cyclischen ketonen.
ATE90101T1 (de) Verfahren zur herstellung von makrolid-derivaten.

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
EEIH Change in the person of patent owner